ECDC report on Creutzfeldt–Jakob disease in the EU and Norway

news

The new report on the prevention of Creutzfeldt–Jakob (vCJD) disease transmission in medical settings provides a comprehensive analysis of the epidemiological situation in EU Member States and Norway. It represents a useful tool for Member States public health experts and policymakers.

ECDC today releases a technical report on the prevention of Creutzfeldt–Jakob (vCJD) disease transmission in medical settings in EU Member States and Norway.

Since its identification in 1996 in the UK, outbreaks of the neurological disease classified as a Transmissible Spongiform Encephalopathy (TSE) occurred in several Member States. Both the European Union and individual countries have implemented special public health measures and strengthened research efforts in the field of human and animal TSEs.

The report provides a review of national documents aimed at controlling the transmission of Creutzfeldt–Jakob disease transmission in medical settings. By thoroughly analysing the epidemiological situation and recent research, it represents a useful tool for Member States in order to identify their specific needs.

Read more:Review of guidelines for prevention of Creutzfeldt–Jakob disease transmission in medical settings in EU Member States and NorwayVariant Creutzfeldt-Jakob disease health topic site